Tsivgoulis Georgios, Triantafyllou Sokratis, Palaiodimou Lina, Grory Brian Mac, Deftereos Spyridon, Köhrmann Martin, Dilaveris Polychronis, Ricci Brittany, Tsioufis Konstantinos, Cutting Shawna, Magiorkinis Gkikas, Krogias Christos, Schellinger Peter D, Dardiotis Efthymios, Rodriguez-Campello Ana, Cuadrado-Godia Elisa, Aguiar de Sousa Diana, Sharma Mukul, Gladstone David J, Sanna Tommaso, Wachter Rolf, Furie Karen L, Alexandrov Andrei V, Yaghi Shadi, Katsanos Aristeidis H
From the Second Department of Neurology (G.T., S.T., L.P., A.H.K.) and Second Department of Cardiology (S.D.), School of Medicine, "Attikon" Hospital, First Department of Cardiology (P.D., K.T.), School of Medicine, Hippokration Hospital, and Hygiene, Epidemiology and Medical Statistics, Medical School (G.M.), National and Kapodistrian University of Athens, Greece; Department of Neurology (G.T., A.V.A.), University of Tennessee Health Science Center, Memphis; Duke University School of Medicine (B.M.G.), Durham, NC; Department of Neurology (M.K.), Universitätsklinikum Essen, Germany; Department of Neurology (B.R., S.C., K.L.F.), Alpert Medical School, Brown University, Providence, RI; Department of Neurology (C.K.), St. Josef-Hospital, Ruhr University, Bochum; Departments of Neurology and Neurogeriatry (P.D.S.), Johannes Wesling Medical Center, Ruhr University Bochum, Minden, Germany; Department of Neurology (E.D.), University of Thessaly, Larissa, Greece; Stroke Unit (A.R.-C., E.C.-G.), Department of Neurology, Group of Research on Neurovascular Diseases, Hospital Del Mar Medical Research Institute. DCEX, Universitat Pompeu Fabra, Universitat Autonoma de Barcelona, Spain; Department of Neurosciences (Neurology) (D.A.d.S.), Hospital de Santa Maria, University of Lisbon, Portugal; Division of Neurology (M.S., A.H.K.), McMaster University and Population Health Research Institute, Hamilton; Sunnybrook Research Institute and Hurvitz Brain Sciences Program (D.J.G.), Sunnybrook Health Sciences Centre, and Department of Medicine, University of Toronto, Canada; Fondazione Policlinico Gemelli IRCCS (T.S.); Catholic University of the Sacred Heart (T.S.), Institute of Cardiology, Rome, Italy; Clinic and Policlinic for Cardiology (R.W.), University Hospital Leipzig, Germany; and Department of Neurology (S.Y.), New York University School of Medicine, NY.
Neurology. 2022 May 10;98(19):e1942-e1952. doi: 10.1212/WNL.0000000000200227. Epub 2022 Mar 9.
Prolonged poststroke cardiac rhythm monitoring (PCM) reveals a substantial proportion of patients with ischemic stroke (IS) with atrial fibrillation (AF) not detected by conventional rhythm monitoring strategies. We evaluated the association between PCM and the institution of stroke preventive strategies and stroke recurrence.
We searched MEDLINE and SCOPUS databases to identify studies reporting stroke recurrence rates in patients with history of recent IS or TIA receiving PCM compared with patients receiving conventional cardiac rhythm monitoring. Pairwise meta-analyses were performed under the random effects model. To explore for differences between the monitoring strategies, we combined direct and indirect evidence for any given pair of monitoring devices assessed within a randomized controlled trial (RCT).
We included 8 studies (5 RCTs, 3 observational; 2,994 patients). Patients receiving PCM after their index event had a higher rate of AF detection and anticoagulant initiation in RCTs (risk ratio [RR] 3.91, 95% CI 2.54-6.03; RR 2.16, 95% CI 1.66-2.80, respectively) and observational studies (RR 2.06, 95% CI 1.57-2.70; RR 2.01, 95% CI 1.43-2.83, respectively). PCM was associated with a lower risk of recurrent stroke during follow-up in observational studies (RR 0.29, 95% CI 0.15-0.59), but not in RCTs (RR 0.72, 95% CI 0.49-1.07). In indirect analyses of RCTs, the likelihood of AF detection and anticoagulation initiation was higher for implantable loop recorders compared with Holter monitors and external loop recorders.
PCM after an IS or TIA can lead to higher rates of AF detection and anticoagulant initiation. There is no solid RCT evidence supporting that PCM may be associated with lower stroke recurrence risk.
延长中风后心脏节律监测(PCM)发现,相当一部分缺血性中风(IS)合并心房颤动(AF)的患者未被传统节律监测策略检测到。我们评估了PCM与中风预防策略的制定及中风复发之间的关联。
我们检索了MEDLINE和SCOPUS数据库,以确定报告近期有IS或短暂性脑缺血发作(TIA)病史的患者接受PCM与接受传统心脏节律监测的患者中风复发率的研究。在随机效应模型下进行成对荟萃分析。为了探索监测策略之间的差异,我们在随机对照试验(RCT)中对任何给定的一对监测设备的直接和间接证据进行了合并。
我们纳入了8项研究(5项RCT,3项观察性研究;2994例患者)。在RCT(风险比[RR] 3.91,95%可信区间[CI] 2.54 - 6.03;RR 2.16,95% CI 1.66 - 2.80)和观察性研究(RR 2.06,95% CI 1.57 - 2.70;RR 2.01,95% CI 1.43 - 2.83)中,索引事件后接受PCM的患者房颤检测率和抗凝启动率更高。在观察性研究中,PCM与随访期间中风复发风险较低相关(RR 0.29,95% CI 0.15 - 0.59),但在RCT中并非如此(RR 0.72,95% CI 0.49 -